The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Ipsen
Research Funding - Bayer
A randomized phase II study to compare the efficacy of upfront bi-monthly rotations between pazopanib (PAZ) and everolimus (EVE) versus sequential treatment of first-line PAZ and second-line EVE until progression in patients with metastatic clear cell renal cell cancer (ccRCC) (ROPETAR trial).
 
Geert A. Cirkel
Travel, Accommodations, Expenses - Novartis
 
Paul Hamberg
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi
 
Stefan Sleijfer
Speakers' Bureau - GlaxoSmithKline
Research Funding - AB Science; Sanofi
Patents, Royalties, Other Intellectual Property - Test on circulating tumor cells in prostate cancer
Travel, Accommodations, Expenses - Amgen
 
Olaf Loosveld
No Relationships to Disclose
 
Wouter Dercksen
No Relationships to Disclose
 
Maartje Los
No Relationships to Disclose
 
John B. A. G. Haanen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
 
Marco Polee
No Relationships to Disclose
 
Franchette van den Berkmortel
No Relationships to Disclose
 
Maureen J.B. Aarts
No Relationships to Disclose
 
Laurens Victor Beerepoot
No Relationships to Disclose
 
Gerard Groenewegen
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Roche
 
Martijn P. Lolkema
Consulting or Advisory Role - Amgen; Roche; Sanofi
Research Funding - Astellas Pharma; Johnson & Johnson; Sanofi
 
Metin Tascilar
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Novartis; Roche
 
Johanna Elisabeth A. Portielje
No Relationships to Disclose
 
Frank PJ Peters
No Relationships to Disclose
 
Heinz Josef Klümpen
No Relationships to Disclose
 
Vincent van de Noort
No Relationships to Disclose
 
Emile E. Voest
Consulting or Advisory Role - Biogeneration Ventures; InteRNA
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)